Antihyperlipidemic compounds

InformationBatefenterol (GSK961081, TD-5959) is both amuscarinic receptorantagonist and aβ2-adrenoceptoragonist with Ki of 1.4 nM, 1.3 nM and 3.7 nM for hM2, hM3 muscarinic receptors and hβ2-adrenoceptor, respectively.TargetshM3 muscarinic receptor

InformationBatefenterol (GSK961081, TD-5959) is both amuscarinic receptorantagonist and aβ2-adrenoceptoragonist with Ki of 1.4 nM, 1.3 nM and 3.7 nM for hM2, hM3 muscarinic receptors and hβ2-adrenoceptor, respectively.TargetshM3 muscarinic receptor

InformationBatefenterol (GSK961081, TD-5959) is both amuscarinic receptorantagonist and aβ2-adrenoceptoragonist with Ki of 1.4 nM, 1.3 nM and 3.7 nM for hM2, hM3 muscarinic receptors and hβ2-adrenoceptor, respectively.TargetshM3 muscarinic receptor

InformationBatefenterol (GSK961081, TD-5959) is both amuscarinic receptorantagonist and aβ2-adrenoceptoragonist with Ki of 1.4 nM, 1.3 nM and 3.7 nM for hM2, hM3 muscarinic receptors and hβ2-adrenoceptor, respectively.TargetshM3 muscarinic receptor

Product introductionEpimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity.

Product introductionEpimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity.

Product introductionEpimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity.

Product introductionEpimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity.

Hispidin is a phenolic compound, that is obtained from a medicinal mushroom, Phellinus linteus . Biochem/physiol Actions Hispidin exhibits robust antioxidant, anticancer and antidiabetic properties.

Application:Ligustroflavone, extracted from Ligustrum lucidum, is a potential candidate as calcium-sensing receptor (CaSR) antagonist. Ligustroflavone exhibits protective effects against diabetic osteoporosis in mice.

m-PEG5-Ms is a PEG derivative containing a mesyl group. The mesyl group is a good leaving group for nucleophilic substitution reactions. The hydrophilic PEG spacer increases solubility in aqueous media.

Selective and reversible lysophospholipase 1 (LYPLA1) inhibitor.